Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

NCT04688801 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Gastroesophageal Cancer
Immunotherapy
Adjuvant

Interventions

DRUG: Chemotherapy Drugs, Cancer
DRUG: Immunotherapy

Sponsor

The Second Hospital of Shandong University